Jefferies Financial Group Begins Coverage on Rhythm ... - MarketBeat

Jan 2, 2025 · A number of other analysts have also recently commented on the company. The Goldman Sachs Group upped their price objective on Rhythm Pharmaceuticals from $59.00 to $66.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. …

$59.00
OFF

Jefferies Financial Group Begins Coverage On Rhythm ... - MarketBeat

1 week from now

marketbeat.com

80%
OFF

Jefferies Starts Rhythm Pharmaceuticals With Buy On Obesity …

1 week from now

Jan 2, 2025 · Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target The firm sees an 80%-85% probability of …

yahoo.com

$80
OFF

Rhythm Pharmaceuticals Initiated With A Buy At Jefferies

1 week from now

Dec 31, 2024 · Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target Discover the latest stocks recommended by top …

businessinsider.com

$80
OFF

Rhythm Pharmaceuticals Initiated With A Buy At Jefferies

1 week from now

Dec 31, 2024 · Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target Don't Miss Our New Year's Offers:Discover the …

nasdaq.com

$80
OFF

Jefferies Initiates Rhythm Pharmaceuticals At Buy With $80 Price …

1 week from now

Jan 2, 2025 · Rhythm Pharmaceuticals, Inc. and Axovia Therapeutics, Inc. Announce Joint Research Collaboration in Bardet-Biedl Syndrome 24-10-24: CI Guggenheim Initiates …

marketscreener.com

02%
OFF

Rhythm Pharmaceuticals Buy Jefferies Financial Group Inc.

1 week from now

Jan 2, 2025 · This prediction is currently active. The prediction for Rhythm Pharmaceuticals disappoints with a performance of -11.02%. This prediction currently runs until 02.01.26. The …

sharewise.com

3%
OFF

Jefferies Reports Record Growth And Financial Health

1 week from now

Jan 8, 2025 · Jefferies Financial Group raises quarterly dividend by 14.3% $0.40/ share Seeking Alpha 2d Jefferies Financial Group GAAP EPS of $0.91 misses by $0.06, Total net revenue of …

businessinsider.com

$245.00
OFF

Talen Energy (NASDAQ:TLN) Price Target Raised To $245.00

1 week from now

Dec 16, 2024 · Jefferies Financial Group began coverage on Talen Energy in a research note on Friday, September 13th. They set a “buy” rating and a $226.00 price objective for the company.

etfdailynews.com

$175.00
OFF

Cantor Fitzgerald Begins Coverage On Snowflake (NYSE:SNOW)

1 week from now

16 hours ago · DA Davidson reiterated a "buy" rating and issued a $175.00 target price on shares of Snowflake in a report on Thursday, October 3rd. Jefferies Financial Group increased their …

marketbeat.com

FAQs about Jefferies Financial Group Begins Coverage on Rhythm ... - MarketBeat Coupon?

Can Oppenheimer buy Rhythm Pharmaceuticals (rhythm)?

Oppenheimer started coverage on Rhythm Pharmaceuticals in a report on Friday, December 20th. They set an “outperform” rating and a $76.00 price target on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 target price on shares of Rhythm Pharmaceuticals in a research note on Tuesday, November 19th. ...

Is Jefferies a good investment?

The company has returned $6.4 billion to shareholders over seven years and had its credit ratings upgraded, indicating robust financial health and stakeholder alignment. Jefferies is a global investment banking and capital markets firm that operates across all sectors and regions, with key hubs in New York, London, and Hong Kong. ...

Which hedge funds have changed their positions in Rhythm Pharmaceuticals?

Hedge funds and other institutional investors have recently made changes to their positions in the business. ORG Wealth Partners LLC acquired a new position in shares of Rhythm Pharmaceuticals in the third quarter valued at about $63,000. Quest Partners LLC grew its position in shares of Rhythm Pharmaceuticals by 513.3% during the 2nd quarter. ...

Is Jefferies a good HC group?

Jefferies has been arguably the most active group in the middle market HC services space since the mid 2010s. Heard it's a very button-up culture vs. some other groups that are more easygoing. Really strong exits to NYC MM HC-specific PE funds. I feel every fund I follow in that fund range has at least one ex-Jefferies banker. ...

Is Jefferies a good mm?

Energy #1. Huge year. Industrials pretty good with that SRS/ Home Depot Whale I’ll caveat the below by saying that almost every coverage group has great deal flow by the virtue of Jefferies being the top MM - and playing up to the BB level. ...

What's a good deal with Jefferies?

LevFin - Jefferies’ deals are usually fueled by their LevFin abilities and analysts get great reps within this group since they hold the pen on the models. Exits mostly to MM / UMM FIG - hired a bunch of CS FIG bankers and has since been able to climb up the league tables. Extremely sweaty by the nature of the team that came over from CS. ...